AtriCure 8-K Signals Potential Leadership/Comp Changes
Ticker: ATRC · Form: 8-K · Filed: Jan 4, 2024 · CIK: 1323885
Complexity: simple
Sentiment: neutral
Topics: executive-change, compensation, corporate-governance
TL;DR
**AtriCure filed an 8-K about potential executive changes and compensation, watch for details.**
AI Summary
AtriCure, Inc. filed an 8-K on January 4, 2024, to report an event concerning the departure or election of directors or officers and compensatory arrangements. This filing indicates potential changes in leadership or executive compensation, which could impact the company's strategic direction and financial performance. Investors should monitor subsequent filings for details on who departed or was appointed, and the specifics of any new compensation plans, as these can influence stock valuation and future growth prospects.
Why It Matters
Changes in executive leadership or compensation can signal shifts in company strategy, operational focus, or financial health, directly affecting investor confidence and stock performance.
Risk Assessment
Risk Level: medium — The filing indicates potential changes in leadership or compensation without specific details, creating uncertainty that could impact the stock.
Analyst Insight
A smart investor would await further detailed disclosures from AtriCure, Inc. regarding the specific personnel changes or compensation arrangements before making any investment decisions, as this filing only signals potential events without providing specifics.
Key Players & Entities
- AtriCure, Inc. (company) — the registrant filing the 8-K
- January 4, 2024 (date) — date of earliest event reported and filing date
- 000-51470 (other) — Commission File Number for AtriCure, Inc.
- Delaware (other) — State of incorporation for AtriCure, Inc.
- ATRC (other) — Trading Symbol for AtriCure, Inc. Common Stock
- NASDAQ Global Market (other) — Exchange where AtriCure, Inc. Common Stock is registered
FAQ
What is the primary purpose of AtriCure, Inc.'s 8-K filing dated January 4, 2024?
The primary purpose of AtriCure, Inc.'s 8-K filing on January 4, 2024, is to report information under 'Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' and 'Item 9.01 Financial Statements and Exhibits'.
What is AtriCure, Inc.'s trading symbol and on which exchange is its common stock registered?
AtriCure, Inc.'s trading symbol is ATRC, and its Common Stock, with a $.001 par value, is registered on the NASDAQ Global Market.
What is the business address and phone number of AtriCure, Inc. as stated in the filing?
AtriCure, Inc.'s business address is 7555 Innovation Way, Mason, OH 45040, and its business phone number is (513) 755-4100.
Is AtriCure, Inc. classified as an emerging growth company according to this 8-K filing?
No, AtriCure, Inc. is not classified as an emerging growth company, as indicated by the 'o' (unchecked box) next to 'Emerging growth company' in the filing.
What is the Central Index Key (CIK) for AtriCure, Inc.?
The Central Index Key (CIK) for AtriCure, Inc. is 0001323885.
Filing Stats: 710 words · 3 min read · ~2 pages · Grade level 11.3 · Accepted 2024-01-04 08:00:11
Filing Documents
- atrc-20240104.htm (8-K) — 29KB
- atrc-20240104xexx991.htm (EX-99.1) — 12KB
- image_0.jpg (GRAPHIC) — 3KB
- 0001323885-24-000004.txt ( ) — 172KB
- atrc-20240104.xsd (EX-101.SCH) — 2KB
- atrc-20240104_lab.xml (EX-101.LAB) — 23KB
- atrc-20240104_pre.xml (EX-101.PRE) — 12KB
- atrc-20240104_htm.xml (XML) — 3KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits No. Description 99.1 Press Release dated January 4, 2024 104 Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATRICURE, INC. Dated: January 4, 2024 By: /s/ Angela L. Wirick Angela L. Wirick Chief Financial Officer